News & publications > News > Atlantis Healthcare Shortlisted for Three Awards at PMEA 2017

Atlantis Healthcare Shortlisted for Three Awards at PMEA 2017

Monday, 02 October 2017
 
Atlantis Healthcare is delighted to have been shortlisted for three awards at PMEA 2017!

Our ‘On Path’ program, developed with Amgen, has been nominated in the following categories:

• Excellence in Patient Education and Support
• Excellence in Marketing New Products
• Excellence in Creating Value Beyond the Product

The On Path team (pictured here) developed a program to empower patients dealing with high cholesterol, to better self-manage their condition and positively change their outcomes.

Matthew Walls, Chairman and CEO of Atlantis Healthcare said: ‘This is a fantastic acknowledgement of the success of On Path. The program’s strategic and innovative approach has enabled patients to gain value beyond the drug and help realize the drug’s potential to improve patient outcomes in a highly competitive market.’ Winners of PMEA 2017 will announced on November 15, 2017 at the Sheraton Grand London Park Lane.
 

About Atlantis Healthcare Group

Atlantis Healthcare leverages health psychology to develop and deliver uniquely personalized healthcare solutions that drive sustained improvement in patient outcome through self-management and treatment adherence across chronic diseases.

With the largest team of globally recognized health psychology experts in a commercial setting, supported by digital creative experts, Atlantis Healthcare uses clinically proven models and academic research to develop award-winning behavior change programs, helping patients achieve better health outcomes. The group provides solutions and services across the globe from offices in UK, Germany, Spain, US, Australia and New Zealand.